Inotersen Sodium and Signifor (Pasireotide Extended-Release Injection)
Determining the interaction of Inotersen Sodium and Signifor (Pasireotide Extended-Release Injection) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotersen
Brand name: Tegsedi
Synonyms: Inotersen
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Signifor, Signifor Injection
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotersen Sodium-Signifor (Pasireotide Injection)
- Inotersen Sodium-Signifor Injection
- Inotersen Sodium-Signifor LAR
- Inotersen Sodium-Signifor LAR Injection
- Inotersen Sodium-Siklos
- Inotersen Sodium-Siladryl Allergy
- Signifor (Pasireotide Extended-Release Injection)-Inotersen Subcutaneous
- Signifor (Pasireotide Extended-Release Injection)-Inotuzumab ozogamicin
- Signifor (Pasireotide Extended-Release Injection)-Inotuzumab ozogamicin Intravenous
- Signifor (Pasireotide Extended-Release Injection)-Inova
- Signifor (Pasireotide Extended-Release Injection)-Inova 4/1 topical
- Signifor (Pasireotide Extended-Release Injection)-Inova 8/2 topical